- Associated Press - Wednesday, June 4, 2014

LANSING, Mich. (AP) - A multinational drugmaker is paying Michigan, 43 other states and the District of Columbia $105 million to settle complaints that the company unlawfully marketed three drugs.

Michigan Attorney General Bill Schuette announced Wednesday that Michigan’s share of the settlement is $2.6 million. The settlement resolves allegations that London-based GlaxoSmithKline illegally marketed Advair, Paxil and Wellbutrin for purposes that hadn’t been approved by the Food and Drug Administration.

GSK is prohibited from disseminating information that describes any so-called off-label use.

The asthma drug Advair is Glaxo’s best-selling product. Paxil and Wellbutrin are antidepressants.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide